Concepedia
Statistics
Publications
19
Citations
1.2K
H-Index
16
Active since
1995
Affiliations
Bristol-Myers Squibb (United States)(Current)
Bristol-Myers Squibb (Germany)
Bristol-Myers Squibb (Sweden)
Paul Falk is an author at Bristol-Myers Squibb (United States) specializing in life sciences, antiviral therapy, and microbiology.
Publications per year
1995–2022
4-Thiazolidinones: novel inhibitors of the bacterial enzyme murB
Charles J. Andres, Joanne J. Bronson, Stanley V. D’Andrea et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 220 citations
Life Sciences, Medicinal Chemistry, Microbiology +9
Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
Fiona McPhee, Amy K. Sheaffer, Jacques Friborg et al. · Antimicrobial Agents and Chemotherapy · 2012 · 184 citations · Full text
Pharmacy, Infectious Diseases, Molecular Biology +17
Resistance Analysis of Hepatitis C Virus Genotype 1 Prior Treatment Null Responders Receiving Daclatasvir And Asunaprevir
Fiona McPhee, Dennis Hernandez, Fei Yu et al. · Hepatology · 2013 · 121 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir
Fiona McPhee, Jacques Friborg, Steven M. LeVine et al. · Antimicrobial Agents and Chemotherapy · 2012 · 110 citations · Full text
Life Sciences, Infectious Diseases, Microbiology +17
Discovery of the first antibacterial small molecule inhibitors of MurB
Joanne J. Bronson, Kenneth DenBleyker, Paul Falk et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 89 citations
Pharmacy, Medicinal Chemistry, Pharmacology +12
1–5 of 19